Treatment of morbid obesity with the Swedish adjustable gastric band (SAGB): Complication rate during a 12-month follow-up period

Background. The Swedish adjustable gastric band (SAGB) is used to treat morbid obesity. However; no quantitative data are available describing the follow-up of these patients with respect to the frequency and the complication rate of inflating and deflating the adjustable system. Methods. We prospectively investigated 207 morbidly obese patients. All patients completed IE months of follow-up and were seen in intervals of 1 to 3 months on an outpatient basis. Results. A total of 207 patients had 1692 consultations (8.3 +/- 2.4 consultations per patient per year [mean +/- SD]) 920 port-a-cath punctions (4.6 +/- 2.0), 820 inflations (4.1 +/- 1.6), and 100 deflations (1.4 +/- 0.6). Complications related to the port-a-cath (n = 6, 2.9% of all patients) were I leakage of the tube (0.5 %), 2 disconnections of the connecting tube (1.0 %), and 3 reimplantations of the port-a-cath as a result of discomfort (1.4%). Complications related to the SAGB (n = 10, 4.8%) were 6 leakages of the band (2.9%), 2 penetrations (1.0 %) 1 intraoperative perforation of the esophagus (0.5 (ro), and I dystopically implanted SAGE (0.5%). Additionally, 9 miller early postoperative wound infections (4.3 %) were recorded. Conclusions. Follow-up can be safely performed on an outpatient basis after implantation of a SAGE without infectious and other minor complications directly linked to the filling procedure.